Tau phosphorylation in Alzheimer's disease - Potential involvement of an APP-MAP kinase complex

被引:35
|
作者
Peel, AL
Sorscher, N
Kim, JY
Galvan, V
Chen, S
Bredesen, DE
机构
[1] Buck Inst Age Res, Novato, CA 94945 USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
关键词
MKK6; p38; MAPK; PHF; neurofibrillary tangle; senile plaque; neuro-degeneration; mitogen-associated protein kinase; stress-associated protein kinase;
D O I
10.1385/NMM:5:3:205
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The two predominant pathological concomitants of,Alzheimer's disease (AD) are senile plaques and neurofibrillary tangles. Although many biochemical studies have addressed the composition and formation of these AD hallmarks, very little is known about the interrelationship between the two. Here we present evidence that the tau phosphorylation characteristic of neurofibrillary tangles may be mediated by a physical association of MKK6 (mitogen-associated protein kinase kinase 6) with tau and subsequent phosphorylation of tau by the MKK6 substrate, p38 MAPK; and that APP (beta-amyloid precursor protein) may be co-immunoprecipitated both with MKK6 and its upstream MAPKKK, ASK1. Taken together with recent data demonstrating APP dimerization by beta-amyloid peptide (Abeta) (Lu et al., 2003), and the possible activation of ASK1 via APP dimerization (Hashimoto et al., 2003), these results suggest a model of AD in which Abeta peptide dimerizes APP directly, leading to the activation of ASK1, MKK6, and p38, with subsequent phosphorylation of tau at sites characteristic of AD.
引用
收藏
页码:205 / 218
页数:14
相关论文
共 50 条
  • [1] Tau phosphorylation in Alzheimer’s diseasePotential involvement of an APP-MAP kinase complex
    Alyson L. Peel
    Noah Sorscher
    Joseph Y. Kim
    Veronica Galvan
    Sylvia Chen
    Dale E. Bredesen
    NeuroMolecular Medicine, 2004, 5 : 205 - 218
  • [2] APP and tau phosphorylation in Alzheimer's disease.
    Davies, P
    DeBernardis, J
    Espinoza, M
    Stahl, M
    Vianna, C
    BRAIN PATHOLOGY, 2000, 10 (04) : 493 - 493
  • [3] Modulation of Tau Phosphorylation by the Kinase PKR: Implications in Alzheimer's Disease
    Bose, Anindita
    Mouton-Liger, Francois
    Paquet, Claire
    Mazot, Pierre
    Vigny, Marc
    Gray, Francoise
    Hugon, Jacques
    BRAIN PATHOLOGY, 2011, 21 (02) : 189 - 200
  • [4] Tau phosphorylation in Alzheimer's disease
    Hanger, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S100 - S100
  • [5] SECRETED BETA-APP STIMULATES MAP KINASE AND PHOSPHORYLATION OF TAU IN NEURONS
    GREENBERG, SM
    KOSIK, KS
    NEUROBIOLOGY OF AGING, 1995, 16 (03) : 403 - 407
  • [6] Phosphorylation of MAP 1A regulates hyperphosphorylation of Tau in Alzheimer's disease model
    Cai, Biao
    Shao, Nan
    Ye, Ting
    Zhou, Peng
    Si, Wenwen
    Song, Hang
    Wang, Guangyun
    Kou, Junping
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2023, 49 (05)
  • [7] Regulation of tau phosphorylation in Alzheimer's disease
    Lee, VMY
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 107 - 113
  • [8] PKR kinase directly regulates tau expression and Alzheimer's disease-related tau phosphorylation
    Reimer, Lasse
    Betzer, Cristine
    Kofoed, Rikke Hahn
    Volbracht, Christiane
    Fog, Karina
    Kurhade, Chaitanya
    Nilsson, Emma
    Overby, Anna K.
    Jensen, Poul Henning
    BRAIN PATHOLOGY, 2021, 31 (01) : 103 - 119
  • [9] Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice
    Ferrer, I
    NEUROTOXICITY RESEARCH, 2004, 6 (06) : 469 - 475
  • [10] The Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer's Disease
    Zhao, Yanfang
    Gu, Yujin
    Zhang, Qili
    Liu, Hongliang
    Liu, Yingying
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)